MedPath

Comparison of the Influence of tDCS and tACS Treatment on Pain Perception and Severity of Symptoms in Patients with Migraine

Not Applicable
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20221230056984N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Suffering from migraine based on the diagnosis of one of internal neurologists, neurologists and pain specialists

Exclusion Criteria

Having a history of hospitalization in a psychiatric hospital
Suffering from severe depression or anxiety
Having a history of cardiovascular diseases (such as high blood pressure)
Addiction to alcohol or other substances
Suffering from other forms of headache, including tension headaches, sinusitis, and headaches caused by drug abuse
Suffering from neurological disorders such as epilepsy, stroke, head and neck trauma, and cerebrovascular diseases
Starting the use of medication (in case of first visit) or changing the prescribed medication, from two weeks before the intervention to two weeks after the end of the intervention.
Previous history of receiving any other brain stimulation
Not having at least primary education

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain Perception Score. Timepoint: Before starting and after the ending of intervention. Method of measurement: McGill Pain Perception Questionnaire (MPQ).;Severity of migraine symptoms. Timepoint: Before starting and after the ending of intervention. Method of measurement: Ahvaz Migraine Questionnaire (AMQ).;Migraine duration. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Severity of migraine attack. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Number of migraine attacks. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath